BitcoinSistemi
2025-08-27 11:09:08

US-Based Healthcare Company Takes Action to Purchase Billions of Dollars in Bitcoin! Here Are the Details

Nasdaq-listed healthcare services company KindlyMD announced plans to issue up to $5 billion in stock to expand its Bitcoin-focused strategy. Nasdaq Company KindlyMD Aims to Grow Its Bitcoin Treasury with $5 Billion in Shares The company will sell its shares gradually through the at-the-market (ATM) method, as part of its registration application submitted to the U.S. Securities and Exchange Commission (SEC). The company's statement stated that the proceeds will be used for general corporate purposes, but its top priority is to expand its Bitcoin treasury. Shares will be offered at market prices through brokers such as TD Securities, Cantor Fitzgerald, and B. Riley Securities. KindlyMD's move follows its recent merger with Bitcoin-focused Nakamoto Holdings, which saw the firm make its first major crypto move by purchasing 5,744 BTC. Industry analysts note that KindlyMD's strategy follows the institutional Bitcoin treasury model pioneered by MicroStrategy founder Michael Saylor. It's reported that many companies currently hold Bitcoin and Ethereum in their reserves, and they're also beginning to focus on altcoins like Solana, BNB, and XRP. According to Google Finance data, KindlyMD (NAKA) shares closed down 12% at $8.07 on Tuesday, while the price of Bitcoin rose 1.40% in the last 24 hours to $112,370. This move by the company is considered a new indicator of Wall Street's deepening interest in crypto assets. *This is not investment advice. Continue Reading: US-Based Healthcare Company Takes Action to Purchase Billions of Dollars in Bitcoin! Here Are the Details

Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.